# Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects

> **NCT05997641** · PHASE1 · UNKNOWN · sponsor: **Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)** · enrollment: 96 (actual)

## Conditions studied

- Healthy
- Safety and Tolerability

## Interventions

- **DRUG:** DF-003
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05997641
- **Lead sponsor:** Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-15
- **Primary completion:** 2024-03-23
- **Final completion:** 2025-01
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05997641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05997641, "Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05997641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*